These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18949510)

  • 61. The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications.
    Bautista JM; Wong WM; Pulliam G; Esquivel RF; Fass R
    Dig Dis Sci; 2005 Oct; 50(10):1909-15. PubMed ID: 16187196
    [TBL] [Abstract][Full Text] [Related]  

  • 62. How to differentiate non-erosive reflux disease from functional heartburn.
    Ke MY
    J Dig Dis; 2012 Dec; 13(12):605-8. PubMed ID: 23134478
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: A review.
    Altuwaijri M
    Medicine (Baltimore); 2022 Sep; 101(35):e30487. PubMed ID: 36107559
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A common disease: heartburn. Self-medication with low-dose H2-receptor antagonists].
    Internist (Berl); 1998 Nov; 39(11 Suppl Selbstmedi):1-4. PubMed ID: 9844840
    [No Abstract]   [Full Text] [Related]  

  • 65. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
    Fass R; Inadomi J; Han C; Mody R; O'Neil J; Perez MC
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):247-53. PubMed ID: 22155561
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Esophageal spasm: demographic, clinical, radiographic, and manometric features in 108 patients.
    Almansa C; Heckman MG; DeVault KR; Bouras E; Achem SR
    Dis Esophagus; 2012 Apr; 25(3):214-21. PubMed ID: 21951821
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ABC of the upper gastrointestinal tract: Oesophagus: heartburn.
    de Caestecker J
    BMJ; 2001 Sep; 323(7315):736-9. PubMed ID: 11576983
    [No Abstract]   [Full Text] [Related]  

  • 68. Prevalence and Characteristics of Dysphagia Based on a Population-Based Survey.
    Adkins C; Takakura W; Spiegel BMR; Lu M; Vera-Llonch M; Williams J; Almario CV
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):1970-1979.e2. PubMed ID: 31669055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
    J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
    [No Abstract]   [Full Text] [Related]  

  • 70. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
    Kahrilas PJ; Howden CW; Hughes N
    Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alginate controls heartburn in patients with erosive and nonerosive reflux disease.
    Savarino E; de Bortoli N; Zentilin P; Martinucci I; Bruzzone L; Furnari M; Marchi S; Savarino V
    World J Gastroenterol; 2012 Aug; 18(32):4371-8. PubMed ID: 22969201
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trends in the management of gastro-oesophageal reflux disease.
    Lee JM; O'Morain CA
    Postgrad Med J; 1998 Mar; 74(869):145-50. PubMed ID: 9640439
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevalence of heartburn and gastroesophageal reflux disease in the urban Brazilian population.
    Moraes-Filho JP; Chinzon D; Eisig JN; Hashimoto CL; Zaterka S
    Arq Gastroenterol; 2005; 42(2):122-7. PubMed ID: 16127569
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Symptomatic gastroesophageal reflux in acutely hospitalized patients.
    Newton M; Kamm MA; Quigley T; Burnham WR
    Dig Dis Sci; 1999 Jan; 44(1):140-8. PubMed ID: 9952235
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
    Lamers CB
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1630-2. PubMed ID: 12966627
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease.
    Johnson DA; Fennerty MB
    Gastroenterology; 2004 Mar; 126(3):660-4. PubMed ID: 14988819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patient-reported symptoms and burden of eosinophilic esophagitis: evidence from real-world clinical practice.
    Xu X; Kwiatek J; Siddall J; Genofre E; Stirnadel-Farrant H; Katial R
    BMC Gastroenterol; 2024 Aug; 24(1):246. PubMed ID: 39097693
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school population.
    Gunasekaran TS; Dahlberg M; Ramesh P; Namachivayam G
    Dig Dis Sci; 2008 Sep; 53(9):2373-9. PubMed ID: 18204971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
    Poen AC; Otten MH
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.